Search…

Baike Biotech (688276.SH): The clinical trial application for the combined vaccine for adsorbed acellular pertussis (two components) has been approved for use in adults and adolescents.

12/11/2025

The Wise Wealth APP News, Baiker Biology (688276.SH) announced that the company recently received the "Drug Clinical Trial Approval Notification" for the Adsorbed Uncellular Bacterial (Two-Component) and White Break Combination Vaccine (for adults and adolescents) issued by the National Medical Products Administration.

Latest

2 m ago

Vietnam Manufacturing and Export Processing (00422.HK) appoints You Yizhen as an independent non-executive director.

2 m ago

Health Link Co., Ltd. (603707.SH) subsidiary received approval from the US FDA for the registration of the increase in production site for the acetyloxybutyrine injection.

3 m ago

Vietnam Manufacturing and Export Processing (00422.HK) released its performance for the first three quarters with a net loss attributable to shareholders of $1.4091 million, a year-on-year decrease of 25.97%.

3 m ago

The Turkish Minister of Interior Affairs announced the list of victims who died in the plane crash on Tuesday.

3 m ago

International Organization for Migration: "This year, more than 1000 people have died in the central Mediterranean. The International Organization for Migration mourns another tragedy off the coast of Libya, where a boat carrying 49 migrants capsized near the Bouri oil field, with only 7 survivors."

See all latest